🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the UK / NCT07104955
Recruiting Not applicable

Salutare One Referral Software Impact on Multi-Disciplinary Team (MDT) Meetings Effectiveness and Safety

NCT07104955 · tracked via the Priya Life Science UK tracker
Sponsor
Salutare Group Ltd.
Phase
Not applicable
Started
2025-07-31
Last updated
2025-08-05

Condition(s) studied

Cancer (Solid Tumors)Sarcoma

Investigational drug(s) / intervention(s)

MDT referral and review software

MDT referral and review software: Use of the multi-disciplinary team (MDT) meeting software to submit, review and discuss referrals

Study summary

Multi-Disciplinary Team (MDT) meetings are crucial for planning patient care in the National Health Service (NHS), but they can be time-consuming and sometimes lack complete patient information. This can lead to delays in treatment decisions, potentially incomplete care plans, or the need to repeatedly discuss the same patient cases.

This study aims to test a new software called Salutare One Referral. One Referral is designed to make these meetings more efficient and effective. We want to see if this software can help healthcare staff prepare MDT referral information more easily and facilitate a more informed MDT discussion, which could lead to better patient care. If successful, this could help improve how MDTs operate across the NHS.

Eligibility

Sex
ALL
Min age
Max age
Healthy volunteers
No
Inclusion Criteria: * MDT meeting Panel Members, Coordinators and staff submitting MDT referrals will take part in this study. Exclusion Criteria: * MDT meeting Panel Members, Coordinators and staff submitting MDT referrals who are unwilling or unable to take part in the study.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Royal National Orthopaedic Hospital London United Kingdom Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07104955 on ClinicalTrials.gov ↗ ← All trials in the UK